Literature DB >> 14564685

Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells.

Justin G s Won1, Hsiao-Shan Tseng, An-Hang Yang, Kam-Tsun Tang, Tjin-Shing Jap, Ching-Fai Kwok, Chen Hsen Lee, Hong-Da Lin.   

Abstract

The selective intra-arterial calcium stimulation test has greatly facilitated the precise regionalization of insulinomas smaller than 2 cm, which noninvasive techniques (ultrasound [US], computed tomography [CT], magnetic resonance imaging [MRI]) often fail to localize. This study examined not only the role of the test in the localization of insulinomas, but also the responsiveness of 3 beta-cell peptides (insulin, C peptide, and proinsulin) and their relationship to the degree of differentiation of the tumor cells, using percentage decrease of both proinsulin/insulin (P/I) and proinsulin/C peptide (P/C) ratios after stimulation as indices. Ten consecutive surgically proven insulinoma patients each received an injection of calcium into the arteries supplying the pancreas after standard selective angiography and beta-cell peptide levels were measured in samples taken from the right hepatic vein before and 30, 60, 90, 120, and 180 seconds after each injection prior to operation. After surgery, the expressions of the calcium sensing receptor (CaSR) on the resected tumors were assessed by immunohistochemistry. Intra-arterial calcium stimulation with sampling either for insulin or for C peptide correctly predicted the site of insulinoma in 8 of 9 patients or in 7 of 8 patients if the 2 big malignant insulinomas were excluded; thus, the detection rate of this test was 89% and 88%, respectively. Calcium administration stimulated a marked and prompt release of insulin and C peptide simultaneously. Both peaked within 30 to 60 seconds, then declined gradually thereafter, remaining above the baseline at 180 seconds. The magnitude of increase correlated well with the corresponding percentage decrease of P/I and P/C ratios. The response of proinsulin was much less. Immunohistochemistry demonstrated variable membraneous staining for CaSR in normal pancreatic islets and in about 9% of the total normal beta cells, whereas staining in tumor cells was only minimally detectable. We conclude that selective intra-arterial calcium stimulation with hepatic venous sampling either for insulin or for C peptide is a highly sensitive method for the preoperative localization of small insulinomas. Calcium injection stimulates a brisk response of insulin, C peptide, and proinsulin simultaneously and the magnitude of increase of both insulin and C peptide appears to be correlated well with the degree of differentiation of the tumor cells. The exact mechanism by which calcium provokes the release of beta-cell peptides is less clear and whether the CaSR is involved in the mechanism of its action requires further study.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564685     DOI: 10.1016/s0026-0495(03)00200-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  13 in total

1.  Laparoscopic treatment of benign insulinomas localized in the body and tail of the pancreas: a single-center experience.

Authors:  Antonio Toniato; Francesco Meduri; Mirto Foletto; Angelo Avogaro; MariaRosa Pelizzo
Journal:  World J Surg       Date:  2006-10       Impact factor: 3.352

2.  Laparoscopic approach for solitary insulinoma: a multicentre study.

Authors:  A Ayav; L Bresler; L Brunaud; P Boissel
Journal:  Langenbecks Arch Surg       Date:  2004-12-18       Impact factor: 3.445

Review 3.  Occult sporadic insulinoma: localization and surgical strategy.

Authors:  Bassam Abboud; Joe Boujaoude
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

4.  Diagnosis and localization of insulinoma after negative laparotomy by hyperinsulinemic, hypoglycemic clamp and intra-arterial calcium stimulation.

Authors:  Robert A Ritzel; Berend Isermann; Tobias Schilling; Hanns-Peter Knaebel; Markus W Büchler; Peter P Nawroth
Journal:  Rev Diabet Stud       Date:  2004-05-10

5.  Islet hyperplasia in adults: challenge to preoperatively diagnose non-insulinoma pancreatogenic hypoglycemia syndrome.

Authors:  Achim Starke; Christiane Saddig; Barbara Kirch; Cyrus Tschahargane; Peter Goretzki
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

6.  Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience.

Authors:  Jean-Marc Guettier; Anthony Kam; Richard Chang; Monica C Skarulis; Craig Cochran; H Richard Alexander; Steven K Libutti; James F Pingpank; Phillip Gorden
Journal:  J Clin Endocrinol Metab       Date:  2009-02-03       Impact factor: 5.958

7.  [Invasive diagnostic procedures for insulinomas of the pancreas].

Authors:  G Nöldge; M-A Weber; R A Ritzel; M J Werner; H-U Kauczor; L Grenacher
Journal:  Radiologe       Date:  2009-03       Impact factor: 0.635

8.  LOCALIZATION OF PANCREATIC INSULINOMAS WITH ARTERIAL STIMULATION BY CALCIUM AND HEPATIC VENOUS SAMPLING - PRESENTATION OF A SINGLE CENTRE EXPERIENCE.

Authors:  D Perkov; L Novosel; M Baretić; D Kastelan; R Smiljanic; R Stern Padovan
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Jan-Mar       Impact factor: 0.877

9.  USE OF A CONTINUOUS GLUCOSE MONITOR FOR PREOPERATIVE MONITORING AND TREATMENT OF HYPOGLYCEMIA IN A CASE OF PANCREATIC NEUROENDOCRINE TUMOR.

Authors:  Ryan C Lyerla; Arrsh Bajaj; Rupendra T Shrestha
Journal:  AACE Clin Case Rep       Date:  2019-06-07

10.  PROINSULIN-PREDOMINANT PANCREATIC NEUROENDOCRINE TUMOR-INDUCED HYPOGLYCEMIA AFTER ROUX-EN-Y GASTRIC BYPASS SURGERY.

Authors:  Khary Edwards; Lori de La Portilla; Faryal S Mirza; Pooja Luthra
Journal:  AACE Clin Case Rep       Date:  2019-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.